Arbutus Biopharma Corp Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 12.71M21.07M16.81M1.00M0.75M14.95M23.28M1.49M10.70M5.95M6.01M6.91M10.99M39.02M18.14M6.17M
Operating items
Depreciation & Amortization - Total 0.87M1.02M0.99M0.87M0.61M0.53M0.59M1.09M2.03M2.18M2.03M1.98M
Research & Development 15.65M21.84M20.13M18.04M21.46M38.71M51.51M61.25M62.68M57.93M57.60M49.34M65.50M84.41M73.70M54.04M
Selling, General & Administrative 3.66M4.72M6.39M8.14M5.55M8.68M26.44M39.44M16.13M16.00M17.73M14.85M17.14M17.83M22.48M22.11M
Restructuring Costs 0.46M9.66M4.80M0.16M0.06M3.72M
Other Operating Expenses 0.005.84M39.01M391.35M40.80M14.81M72.40M-1.50M1.87M2.23M0.07M2.62M
Operating Expenses 20.18M33.43M27.51M27.05M27.62M48.39M127.19M493.13M121.63M95.72M149.91M64.72M84.51M104.47M96.24M82.49M
Operating Income -7.47M-12.35M-10.69M-12.93M-12.15M-33.43M-103.92M-491.64M-110.93M-89.78M-143.90M-57.81M-73.52M-65.46M-78.10M-76.32M
EBIT -7.47M-12.35M-10.69M-12.93M-12.15M-33.43M-103.92M-491.64M-110.93M-89.78M-143.90M-57.81M-73.52M-65.46M-78.10M-76.32M
Non-operating items
Non Operating Investment Income 24.88M
Interest & Investment Income 0.14M0.11M0.13M0.14M0.54M0.85M0.67M1.39M1.54M3.05M2.11M0.74M0.13M2.19M5.69M6.58M
Other Non Operating Income -0.38M5.75M0.58M-3.82M-3.53M-10.38M21.77M1.12M2.30M-1.00M0.04M-0.12M0.01M-0.02M0.03M-0.05M
Non Operating Income -1.91M-5.40M25.02M2.47M2.20M28.44M-22.48M-5.94M-2.73M0.44M5.25M6.40M
Net income details
EBT -7.32M-12.25M-10.57M-12.79M-14.06M-38.84M-78.90M-489.17M-108.73M-61.34M-166.38M-63.74M-76.25M-65.01M-72.85M-69.92M
Tax Provisions -16.18M-105.00M-24.32M-4.28M-12.66M4.44M
Profit After Tax -7.71M-12.25M-10.08M29.61M-14.06M-38.84M-62.72M-384.16M-84.41M-57.06M-153.72M-63.74M-76.25M-69.46M-72.85M-69.92M
Equity Income -5.56M-22.52M-2.54M
Investment Income 4.61M4.55M32.72M
Income from Continuing Operations -7.32M-12.25M-10.57M-12.79M-14.06M-38.84M-62.72M-384.16M-84.41M-57.06M-153.72M-63.74M-76.25M-69.46M-72.85M-69.92M
Consolidated Net Income -7.32M-12.25M-10.57M-12.79M-14.06M-38.84M-62.72M-384.16M-84.41M-57.06M-153.72M-63.74M-76.25M-69.46M-72.85M-69.92M
Income towards Parent Company -7.32M-12.25M-10.57M-12.79M-14.06M-38.84M-62.72M-384.16M-84.41M-57.06M-153.72M-63.74M-76.25M-69.46M-72.85M-69.92M
Preferred Dividend Payments 0.91M10.09M11.15M12.12M12.14M
Net Income towards Common Stockholders -7.32M-12.25M-10.57M-12.79M-14.06M-38.84M-62.72M-384.16M-85.32M-67.15M-164.87M-75.87M-88.39M-69.46M-72.85M-69.92M
Additional items
EPS (Basic) -0.75-1.18-0.892.16-0.92-1.80-1.38-7.24-1.56-1.21-2.89-1.00-0.83-0.46-0.44-0.38
EPS (Weighted Average and Diluted) -1.18-0.892.07-0.92-1.80-1.38-7.24-1.56-1.21-1.00-0.83-0.46-0.44-0.38
Shares Outstanding (Weighted Average) 10.33M10.33M10.34M12.15M14.31M22.31M54.57M54.84M55.05M55.48M56.85M95.58M135.27M156.47M167.70M189.49M
Shares Outstanding (Diluted Average) 10.20M11.45M14.33M14.59M21.60M45.46M53.07M54.72M55.30M75.84M106.24M150.94M165.96M185.61M
EBITDA -6.60M-11.33M-10.14M30.09M-17.20M-45.33M-88.59M-384.16M-84.41M-57.05M-153.78M-63.69M-76.41M-71.61M-70.78M-69.63M
Interest Expenses 0.26M0.23M2.11M4.01M2.86M1.73M0.46M0.14M
Shares Outstanding 9.10M10.20M12.29M14.31M18.16M22.44M54.57M54.84M55.06M55.52M64.78M89.68M144.99M157.46M169.87M189.96M
Tax Rate 20.5121.4722.376.987.61